Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.

This publication has 19 references indexed in Scilit:

• The effects of anti-asthma drugs on mediator release from cultured human mast cells
  Clinical and Experimental Allergy, 1998
• Azelastine suppresses the release of arachidonic acid metabolites from cultured human umbilical vein endothelial cells
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 1997
• ALLERGIC CONJUNCTIVITIS
  Immunology and Allergy Clinics of North America, 1997
• Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti‐allergic activity
  Clinical and Experimental Allergy, 1997
• Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: An antiallergic activity☆☆☆★★★
  Journal of Allergy and Clinical Immunology, 1996
• The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients
  Life Sciences, 1995
• Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy
  Survey of Ophthalmology, 1993
• The Effect of Antihistamines on the Immediate Allergic Response: A Comparative Review
  Otolaryngology -- Head and Neck Surgery, 1993
• The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C
  Inflammation Research, 1989
• Azelastine inhibits IgE-mediated human basophil histamine release
  Journal of Allergy and Clinical Immunology, 1989